Fulvicin - the antifungal antibiotic, which is taken at mycosis of skin, hair and nails (favus, trichophytosis, microsporia of a pilar part of the head, microsporia of smooth skin, dermatomycosis of beard and moustaches, epidermophitia of smooth skin, inguinal epidermophitia, onychomycoses). It is effective concerning fungus of the sort Trichophyton, Microsporum, Epydermophyton, Achorionum; causes disturbance of the structure of a mitotic spindle and synthesis of a cell wall at chitin fungus, suppresses division of fungal cells in metaphase and synthesis of protein because of disruption of linking with template-RNA.
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Fulvicin Product Description
Fulvicin is an antifungal antibiotic, used to treat ringworm and dermatophyte infections of the scalp, hair, nails and skin. The antibiotic violates the structure of the fungal cells and inhibits the reproduction process. Fulvicin has an antimicrobial activity against fungi of the genus Epidermophyton, Trichophyton, and Microsporum.
The antifungal drug Fulvicin is prescribed to children and adult patients for the treatment of:
- tinea barbae (barber's itch)
- tinea pedis (fungal foot infection)
- tinea cruris (ringworm of the groin)
- tinea capitis (ringworm of the hair)
- tinea corporis (ringworm of the body)
Besides, Fulvicin can be successfully used for the treatment of tinea unguium (onychomycosis), if the fungal infection is not sensitive to topical treatments.
The recommended dose for adults is 500 mg per day, while the daily dose for children is 10mg per kg of body weight. Duration of the antifungal therapy usually lasts from 2 to 12 weeks, depending on the type of the causative fungi and the infection severity.
If you missed the prescribed Fulvicin dose, wait until the next dose, and skip the forgotten dose of the antifungal agent. If there is still a lot of time left before the next Fulvicin intake, you can take the missed dose of the antifungal drug, as soon as you remember of it, or as soon as you have a chance.
Fulvicin is able to accumulate in the cells of the skin, hair and nails, and by contacting the newly formed keratin helps to resist the fungal infection. During the antifungal therapy, patients are advised to comply with common hygiene rules (often change socks, bedding, and wash shoes inside). This will reduce the risk of re-infection and the risk of infecting the surrounding people with the fungal infection.
Fulvicin drug should be stored in a dry warm place, away from children, at a temperature of 15°C to 30°C. Do not keep Fulvicin pills in the kitchen or bathroom.
Fulvicin Safety Information
Keep in mind the fact that Fulvicin is able to reduce the effectiveness of oral contraceptives. Therefore, the patients are advised to use additional contraceptive measures during the antifungal therapy. Clinical studies have shown that the antifungal drug Fulvicin may increase sensitivity to light in some patients. Avoid prolonged exposure to direct sunlight.
Review on the antifungal agent Fulvicin contains information about fungal infections, which is provided solely for familiarization purpose only, and shall not be regarded as a substitute for professional medical diagnosis or advice of a dermatologist. The online pharmacy is not liable for any type of damage, which can result from the misuse of information about Fulvicin tablets.
Fulvicin Side Effects
The adverse events in therapy with Fulvicin are infrequent and have a gentle nature. The adverse events of Fulvicin do not lead to serious consequences and usually pass quickly during the treatment. The most common adverse events, caused by Fulvicin, are urticaria, skin rash, headache, thirst, and such gastrointestinal dysfunctions, like heartburn, diarrhea, nausea, flatulence, and vomiting.
Furthermore, Fulvicin may cause the CNS adverse effects, including vertigo, drowsiness and lethargy. For this reason, patients taking the drug are not recommended to drive during the therapy with Fulvicin. The patient should immediately discontinue therapy with Fulvicin in granulocytopenia.